540 related articles for article (PubMed ID: 35576953)
1. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
Alberts CJ; Clifford GM; Georges D; Negro F; Lesi OA; Hutin YJ; de Martel C
Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):724-735. PubMed ID: 35576953
[TBL] [Abstract][Full Text] [Related]
2. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Cirrhosis Collaborators
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
[TBL] [Abstract][Full Text] [Related]
3. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
[TBL] [Abstract][Full Text] [Related]
4. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
Nelson PK; Mathers BM; Cowie B; Hagan H; Des Jarlais D; Horyniak D; Degenhardt L
Lancet; 2011 Aug; 378(9791):571-83. PubMed ID: 21802134
[TBL] [Abstract][Full Text] [Related]
5. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.
Degenhardt L; Charlson F; Stanaway J; Larney S; Alexander LT; Hickman M; Cowie B; Hall WD; Strang J; Whiteford H; Vos T
Lancet Infect Dis; 2016 Dec; 16(12):1385-1398. PubMed ID: 27665254
[TBL] [Abstract][Full Text] [Related]
6. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide.
Maucort-Boulch D; de Martel C; Franceschi S; Plummer M
Int J Cancer; 2018 Jun; 142(12):2471-2477. PubMed ID: 29388206
[TBL] [Abstract][Full Text] [Related]
7. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019.
GBD 2019 Europe Hepatitis B & C Collaborators
Lancet Public Health; 2023 Sep; 8(9):e701-e716. PubMed ID: 37633679
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J
Lancet Glob Health; 2023 May; 11(5):e659-e672. PubMed ID: 36996857
[TBL] [Abstract][Full Text] [Related]
10. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of human immunodeficiency virus, syphilis, and hepatitis B and C virus infections in pregnant women: a systematic review and meta-analysis.
Wu S; Wang J; Guo Q; Lan H; Sun Y; Ren M; Liu Y; Wang P; Wang L; Su R; Zhang J; Chen Y; Li G
Clin Microbiol Infect; 2023 Aug; 29(8):1000-1007. PubMed ID: 36921717
[TBL] [Abstract][Full Text] [Related]
12. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Hepatitis B Collaborators
Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):796-829. PubMed ID: 35738290
[TBL] [Abstract][Full Text] [Related]
13. Global reporting of progress towards elimination of hepatitis B and hepatitis C.
Cui F; Blach S; Manzengo Mingiedi C; Gonzalez MA; Sabry Alaama A; Mozalevskis A; Séguy N; Rewari BB; Chan PL; Le LV; Doherty M; Luhmann N; Easterbrook P; Dirac M; de Martel C; Nayagam S; Hallett TB; Vickerman P; Razavi H; Lesi O; Low-Beer D
Lancet Gastroenterol Hepatol; 2023 Apr; 8(4):332-342. PubMed ID: 36764320
[TBL] [Abstract][Full Text] [Related]
14. The global and regional prevalence of hepatitis C and B co-infections among prisoners living with HIV: a systematic review and meta-analysis.
Ahmadi Gharaei H; Fararouei M; Mirzazadeh A; Sharifnia G; Rohani-Rasaf M; Bastam D; Rahimi J; Kouhestani M; Rezaian S; Dianatinasab M
Infect Dis Poverty; 2021 Jul; 10(1):93. PubMed ID: 34210349
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of hepatitis B virus and/or hepatitis C virus infections among people living with human immunodeficiency virus in Africa: A systematic review and meta-analysis.
Kenfack-Momo R; Kenmoe S; Takuissu GR; Ebogo-Belobo JT; Kengne-Ndé C; Mbaga DS; Tchatchouang S; Oyono MG; Kenfack-Zanguim J; Lontuo Fogang R; Mbongue Mikangue CA; Zeuko'o Menkem E; Ndzie Ondigui JL; Kame-Ngasse GI; Magoudjou-Pekam JN; Taya-Fokou JB; Bowo-Ngandji A; Nkie Esemu S; Kamdem Thiomo D; Moundipa Fewou P; Ndip L; Njouom R
PLoS One; 2022; 17(5):e0269250. PubMed ID: 35639675
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional study.
Yan LB; Rao HY; Ma YJ; Bai L; Chen EQ; Du LY; Yang RF; Wei L; Tang H;
BMJ Open; 2016 Oct; 6(10):e012016. PubMed ID: 27733412
[TBL] [Abstract][Full Text] [Related]
17. Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among People Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study.
Makuza JD; Jeong D; Binka M; Adu PA; Cua G; Yu A; Velásquez García HA; Alvarez M; Wong S; Bartlett S; Karim ME; Yoshida EM; Ramji A; Krajden M; Janjua NZ
Viruses; 2022 Nov; 14(11):. PubMed ID: 36423186
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis B, C, and D virus infection in Haiti: A systematic review and meta-analysis.
Vincent JP; Nyamasege C; Wang S; Madec Y; Shimakawa Y
Front Public Health; 2022; 10():1099571. PubMed ID: 36711383
[TBL] [Abstract][Full Text] [Related]
19. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
20. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
El-Serag HB; Richardson PA; Everhart JE
Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
